Abstract
Atherosclerotic plaques are the underlying cause of most cardiovascular diseases, with myocardial infarction as a major consequence. The development of arterial lesions starts in childhood, and they progress slowly and become clinically manifest only after an event-free interval of many decades. The sudden onset of symptoms is usually initiated by complications in an advanced plaque, such as plaque disruption and superimposed thrombosis [1].
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Davies MJ (1990) A macro and micro view of coronary vascular insult in ischemic heart disease. Circulation 82 (Suppl II): 38–46
Ross R (1993) The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 362: 801–809
Ross R, Glomset JA (1976) The pathogenesis of atherosclerosis. N Engl J Med 295: 369–377, 420–425
Jonasson L, Holm J, Skalli O, Bondjers G, Hansson GK (1986) Regional accumulations of T cells, macrophages and smooth muscle cells in the human atherosclerotic plaque. Arteriosclerosis 6: 131–138
Munro JM, van der Walt JD, Munro CS, Chalmers JAC, Cox EL (1987) An im-munohistochemical analysis of human aortic fatty streaks. Hum Pathol 18: 375–380
Emeson EE, Robertson AL (1988) T lymphocytes in aortic and coronary intimas. Their potential role in atherogenesis. Am J Pathol 130: 369–376
van der Wal AC, Das PK, Bentz van de Berg DB, van der Loos CM, Becker AE (1989) Atherosclerotic lesions in humans. In situ immunophenotypic analysis suggesting an immune mediated response. Lab Invest 61: 166–170
Hansson GK, Holm J, Jonasson L (1989) Detection of activated T lymphocytes in the human atherosclerotic plaque. Am J Pathol 135: 169–175
Stemme S, Holm J, Hansson GK (1991) T lymphocytes in human atherosclerotic plaques are memory cells expressing CD 45RO and the integrin VLA-1. Arterioscler Thromb 12: 206–211
Rekhter MD, Gordon D (1995) Active proliferation of different cell types, including lymphocytes, in the human atherosclerotic plaque. Am J Pathol 147: 668–677
Mondino A, Jenkins MK (1994) Surface proteins involved in T-cell stimulation. J Leukoc Biol 55: 805–815
de Boer OJ, Hirsch F, van der Wal AC, Das PK, Becker AE (1995) T-cell activation in human atherosclerotic plaques: in situ expression of costimulatory molecules. Atherosclerosis 115 (Suppl): S26.
Stemme S, Faber, Holm J, Wiklund O, Witztum JL, Hansson GK (1995) T-lymphocytes from human atherosclerotic plaques recognize oxidized low density lipoprotein. Proc Natl Acad Sci U S A 92: 3893–3897
Parums DV, Brown DL, Mitchinson MJ (1990) Serum antibodies to oxidized LDL and ceroid in chronic priaortitis. Arch Pathol Lab Med 114: 383–387
Solonen JT, Yla-Herttuala S, Yamamoto R (1992) Autoantibody against oxidized LDL and progression of carotid atherosclerosis. Lancet 339: 883–887
Ramshaw AL, Parums DV (1990) Immunohistochemical characterization of inflammatory cells associated with advanced atherosclerosis. Histopathology 17: 543–552
Mitchinson (1987) Macrophages and atherogenesis Lancet ii: 146–148
Witzum JL (1994) The oxidation hypothesis of atherosclerosis Lancet 344; 793–795
van der Wal AC, Das PK, Tigges AJ, Becker AE (1992) Macrophage differentiation in atherosclerosis. An immunohistochemical analysis in humans. Am J Pathol 141: 161–168
Geng YJ, Hansson GK (1992) Interferon gamma inhibits scavenger receptor expression and foam cell formation in human monocyte derived macrophages. J Clin Invest 89: 1322–1330
van der Wal AC, Becker AE, van der Loos CM, Tigges AJ, Das PK (1994) Fibrous and lipid rich atherosclerotic plaques are part of interchangeable morphologies related to inflammation: a concept. Coron Artery Dis 5: 463–469
Davies MJ, Richardson PD, Woolf N, Katz DR, Mann J (1993) Risk of thrombus in human atherosclerotic plaques: role of extracellular lipid, macrophage and smooth muscle cell content. Br Heart J 69: 377–381
Hansson GK, Jonasson L, Holm J, Clowes M, Clowes AW (1988) Gamma interferon regulates vascular smooth muscle proliferation and Ia antigen expression in vivo and in vitro. Circ Res 63: 712–719
Amento EP, Ehsain N, Palmer H, Libby P (1991) Cytokines and growth factors positively and negatively regulate interstitial collagene expression in human vascular smooth muscle cells. Arterioscler Thromb 11: 1223–1230
Warner SJC, Friedman GB, Libby P (1989) Regulation of major histocompatibility gene expression in cultured human vascular smooth muscle cells. Arteriosclerosis 9: 279–288
Hansson GK, Holm J, Holm S, Fotev Z, Hedrich HJ, Fingerle J (1991) T lymphocytes inhibit the vascular response to injury. Proc Natl Acad Sci U S A 88: 10530–10534
Rekhter MD, Zhanb K, Narayanan AS, Phan S, Schork MA, Gordon D (1993) Type I collagen gene expression in human atherosclerosis. Localization to specific plaque regions. Am J Pathol 143: 1634–1648
Galis Z, Sukhova GK, Lark MW, Libby P (1994) Increased expression of matrix-me-talloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. J Clin Invest 94: 2493–2503
Brown DL, Hibbs MS, Kearney M, Loushin C, Isner JM (1995) Identification of 92-kD gelatinase in human coronary atherosclerotic lesions: association of active enzyme synthesis with unstable angina. Circulation 91: 2125–2131
Henney AM, Wakely, Davies MJ, Foster K, Hembry R, Murphy G, Humphries S (1991) Localization of stromelysin gene expression in atherosclerotic plaques by in situ hybridization. Proc Natl Acad Sci U S A 88: 8154–8158
Falk E, Shah PK, Fuster V (1995) Coronary plaque disruption. Circulation 92: 657–671
Richardson PD, Born GVR, Davies MJ (1989) Influence of plaque configuration and stress distribution on Assuring of coronary atherosclerotic plaques. Lancet ii: 941–944
Cheng GC, Loree HM, Kamm RD, Fishbein MC, Lee RT (1993) Distribution of circumferential stress in ruptured and stable atherosclerotic lesions: a structural analysis with histopathological correlation. Circulation 87: 1179–1187
van der Wal AC, Becker AE, van der Loos CM, Das PK (1994) Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology. Circulation 89: 36–44
Moreno PR, Falk E, Palacios IF, Newell JB, Fuster V, Fallon J (1994) Macrophage infiltration in acute coronary syndromes: implications for plaque rupture. Circulation 90: 775–778
Alexander RW (1994) Inflammation and coronary artery disease. N Engl J Med 331: 468–469
Libby P (1995) Molecular bases of the acute coronary syndromes. Circulation 91: 2844–2850
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1997 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
van der Wal, A.C., de Boer, O.J., Becker, A.E. (1997). Immune and Inflammatory Responses in the Human Atherosclerotic Plaque. In: Schultheiss, HP., Schwimmbeck, P. (eds) The Role of Immune Mechanisms in Cardiovascular Disease. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-60463-8_18
Download citation
DOI: https://doi.org/10.1007/978-3-642-60463-8_18
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-61358-9
Online ISBN: 978-3-642-60463-8
eBook Packages: Springer Book Archive